Extracellular Vesicle Protein Analysis

The following antibodies were used in this study: anti-CD9 mouse monoclonal primary antibodies (clone 4A2, cat. SAB1402143) and anti-CD63 mouse monoclonal primary antibodies (clone RFAC4, cat. CBL553) from Sigma-Aldrich (St. Louis, MO, USA), as well as Hsp70 (clone C92F3A-5, cat. sc-66048) and mouse monoclonal primary antibodies for Arf6 (clone 3A-1, cat. sc-7971) from Santa Cruz Biotechnology (Dallas, TX, USA). Other reagents were obtained as listed in [17 (link)].

Free full text: Click here

Surman M., Jankowska U., Wilczak M, & Przybyło M. (2023). Similarities and Differences in the Protein Composition of Cutaneous Melanoma Cells and Their Exosomes Identified by Mass Spectrometry. Cancers, 15(4), 1097.

Publication 2023

Anti antibodies Antibodies Arf6 Clone Hsp70 Monoclonal antibodies Mouse

Corresponding Organization : Jagiellonian University

Top 5 similar protocols

Variable analysis

independent variables

Anti-CD9 mouse monoclonal primary antibodies (clone 4A2, cat. SAB1402143)
Anti-CD63 mouse monoclonal primary antibodies (clone RFAC4, cat. CBL553)
Hsp70 (clone C92F3A-5, cat. sc-66048)
Mouse monoclonal primary antibodies for Arf6 (clone 3A-1, cat. sc-7971)

dependent variables

Measured outcomes using the specified antibodies

control variables

Other reagents not explicitly mentioned, but referred to in [17]

controls

Positive controls: Not explicitly mentioned
Negative controls: Not explicitly mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!